Gino Santini - 22 Sep 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co

Role
Director
Signature
/s/ Meghanne Downes, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
22 Sep 2023
Net transactions value
+$319,200
Form type
4
Filing time
25 Sep 2023, 19:07:06 UTC
Previous filing
28 Jul 2023
Next filing
02 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise $319,200 +20,000 +35% $15.96* 77,867 22 Sep 2023 Direct
holding HZNP Ordinary Shares 18,655 22 Sep 2023 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Stock Option (Right to buy) Options Exercise $0 -20,000 -100% $0.000000* 0 22 Sep 2023 Ordinary Shares 0 $15.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested and exercisable.